Gilead Sciences - GILD Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $83.87
Forecasted Upside: 28.20%
Number of Analysts: 17
Breakdown:
0 Sell Ratings
11 Hold Ratings
6 Buy Ratings
0 Strong Buy Ratings

^$65.42 As of 04/26/2024 01:00 AM ET

▲ +0.15 (0.23%)

1 month | 3 months | 12 months

Get New Gilead Sciences Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for GILD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GILD

^$83.87

▲ +28.20% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $83.87, with a high forecast of $105.00 and a low forecast of $69.00. The average price target represents a 28.20% upside from the last price of $65.42.

Current Consensus is Hold

The current consensus among 17 investment analysts is to hold stock in Gilead Sciences. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

11/3/2022

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

2/1/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

5/2/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

7/31/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

10/29/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

1/27/2024

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

3/27/2024

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

4/26/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/26/2024	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$80.00 ➝ $78.00	Low
4/26/2024	TD Cowen	Lower Target	Buy ➝ Buy	$90.00 ➝ $85.00	Low
4/26/2024	Royal Bank of Canada	Lower Target	Sector Perform ➝ Sector Perform	$76.00 ➝ $74.00	Low
4/26/2024	Needham & Company LLC	Reiterated Rating	Hold		Low
4/24/2024	HSBC	Upgrade	Reduce ➝ Hold	$69.00	Low
4/19/2024	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$105.00	Low
4/17/2024	UBS Group	Lower Target	Neutral ➝ Neutral	$81.00 ➝ $75.00	Low
3/4/2024	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$84.00 ➝ $77.00	Low
2/22/2024	Mizuho	Lower Target	Buy ➝ Buy	$101.00 ➝ $90.00	Low
2/22/2024	Truist Financial	Downgrade	Buy ➝ Hold	$91.00 ➝ $82.00	Low
2/14/2024	Royal Bank of Canada	Lower Target	Sector Perform ➝ Sector Perform	$76.00 ➝ $75.00	Low
2/12/2024	Barclays	Lower Target	Equal Weight ➝ Equal Weight	$85.00 ➝ $80.00	Low
2/12/2024	Oppenheimer	Lower Target	Outperform ➝ Outperform	$115.00 ➝ $105.00	Low
2/7/2024	Cantor Fitzgerald	Lower Target	Neutral ➝ Neutral	$80.00 ➝ $78.00	Low
2/7/2024	Royal Bank of Canada	Lower Target	Sector Perform ➝ Sector Perform	$78.00 ➝ $76.00	Low
2/7/2024	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$90.00 ➝ $84.00	Low
1/23/2024	Barclays	Boost Target	Equal Weight ➝ Equal Weight	$82.00 ➝ $85.00	Low
11/14/2023	Royal Bank of Canada	Lower Target	Sector Perform ➝ Sector Perform	$78.00 ➝ $77.00	Low
11/9/2023	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$75.00	Low
11/8/2023	UBS Group	Lower Target	Neutral ➝ Neutral	$85.00 ➝ $84.00	Low
10/11/2023	Leerink Partnrs	Reiterated Rating	Market Perform		Low
9/8/2023	Bank of America	Upgrade	Neutral ➝ Buy	$88.00 ➝ $95.00	Low
9/6/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$91.00	Low
9/6/2023	HSBC	Initiated Coverage	Reduce	$71.00	Low
8/4/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$86.00 ➝ $88.00	Low
8/4/2023	Royal Bank of Canada	Boost Target	Sector Perform ➝ Sector Perform	$83.00 ➝ $84.00	Low
7/24/2023	Piper Sandler	Lower Target	Overweight	$105.00 ➝ $100.00	Low
7/24/2023	Barclays	Lower Target	Equal Weight	$81.00 ➝ $80.00	Low
7/19/2023	Cantor Fitzgerald	Lower Target	Neutral ➝ Neutral	$85.00 ➝ $80.00	Low
7/18/2023	BMO Capital Markets	Lower Target		$100.00 ➝ $95.00	Low
7/11/2023	Barclays	Lower Target		$84.00 ➝ $81.00	Low
5/16/2023	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$90.00 ➝ $100.00	Low
4/12/2023	Morgan Stanley	Boost Target	Equal Weight	$81.00 ➝ $85.00	Low
3/6/2023	Royal Bank of Canada	Lower Target	Sector Perform	$87.00 ➝ $86.00	Low
2/14/2023	Mizuho	Boost Target	Buy	$88.00 ➝ $101.00	Low
2/10/2023	Cowen	Boost Target		$90.00 ➝ $95.00	Low
2/3/2023	SVB Leerink	Boost Target	Market Perform	$81.00 ➝ $91.00	Low
2/3/2023	Morgan Stanley	Boost Target	Equal Weight	$80.00 ➝ $81.00	Low
2/3/2023	Robert W. Baird	Boost Target		$69.00 ➝ $80.00	Low
2/3/2023	Piper Sandler	Boost Target	Overweight	$111.00 ➝ $112.00	Low
1/24/2023	Morgan Stanley	Lower Target	Equal Weight	$81.00 ➝ $80.00	Low
1/19/2023	Piper Sandler	Boost Target	Overweight	$104.00 ➝ $111.00	Low
1/18/2023	Barclays	Boost Target	Equal Weight	$76.00 ➝ $84.00	Low
1/3/2023	Wells Fargo & Company	Boost Target	Equal Weight	$75.00 ➝ $90.00	Low
1/3/2023	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$87.00	Low
12/21/2022	Mizuho	Initiated Coverage	Buy	$88.00	Low
12/13/2022	Bank of America	Reiterated Rating	Neutral	$85.00	Low
12/9/2022	DZ Bank	Downgrade	Buy ➝ Hold	$90.00	Low
12/1/2022	Morgan Stanley	Boost Target	Equal Weight	$68.00 ➝ $81.00	Low
12/1/2022	Oppenheimer	Boost Target		$95.00 ➝ $105.00	Low
11/9/2022	Argus	Boost Target		$70.00 ➝ $100.00	Low
11/8/2022	Cowen	Boost Target	Outperform	$80.00 ➝ $90.00	Low
11/8/2022	Cowen	Boost Target	Outperform	$80.00 ➝ $90.00	Low
11/8/2022	Mizuho	Boost Target	Buy	$75.00 ➝ $88.00	Low
11/1/2022	Robert W. Baird	Boost Target		$69.00	Low
11/1/2022	SVB Leerink	Boost Target	Market Perform	$68.00 ➝ $81.00	Low
10/31/2022	Maxim Group	Boost Target	Buy	$84.00 ➝ $92.00	Low
10/31/2022	Barclays	Upgrade	Underweight ➝ Equal Weight	$60.00 ➝ $76.00	Low
10/28/2022	Morgan Stanley	Boost Target	Equal Weight	$67.00 ➝ $68.00	Low
10/28/2022	Royal Bank of Canada	Boost Target	Outperform	$79.00 ➝ $82.00	Low
10/28/2022	JPMorgan Chase & Co.	Boost Target	Overweight	$80.00 ➝ $87.00	Low
10/28/2022	Jefferies Financial Group	Boost Target	Buy	$78.00 ➝ $86.00	Low
10/28/2022	Wells Fargo & Company	Boost Target	Equal Weight	$74.00 ➝ $75.00	Low
10/28/2022	Cowen	Boost Target	Outperform	$75.00 ➝ $80.00	Low
10/28/2022	BMO Capital Markets	Boost Target	Market Perform	$63.00 ➝ $72.00	Low
10/28/2022	Cowen	Boost Target		$75.00 ➝ $80.00	Low
10/28/2022	Piper Sandler	Upgrade	Neutral ➝ Overweight	$79.00 ➝ $96.00	N/A
10/28/2022	Truist Financial	Upgrade	Hold ➝ Buy	$76.00 ➝ $91.00	Low
10/13/2022	Morgan Stanley	Boost Target	Equal Weight	$65.00 ➝ $67.00	Low
10/12/2022	Barclays	Boost Target	Underweight	$56.00 ➝ $60.00	Low
10/4/2022	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$72.00 ➝ $80.00	Low
9/15/2022	SVB Leerink	Reiterated Rating	Market Perform		Low
9/15/2022	Truist Financial	Boost Target	Hold	$71.00 ➝ $76.00	Low
9/13/2022	Wells Fargo & Company	Boost Target	Equal Weight	$63.00 ➝ $74.00	Low
9/12/2022	Piper Sandler	Boost Target		$74.00 ➝ $79.00	Low
8/15/2022	Piper Sandler	Boost Target		$71.00 ➝ $74.00	Low
7/15/2022	Morgan Stanley	Boost Target	Equal Weight	$63.00 ➝ $65.00	Low
7/12/2022	Cantor Fitzgerald	Initiated Coverage	Neutral	$70.00	N/A
6/7/2022	BMO Capital Markets	Initiated Coverage	Hold	$63.00	High
5/23/2022	SVB Leerink	Initiated Coverage	Market Perform	$68.00	Low
5/16/2022	Piper Sandler	Lower Target	Neutral	$73.00 ➝ $69.00	N/A
4/29/2022	Piper Sandler	Boost Target		$72.00 ➝ $73.00	High
4/12/2022	Morgan Stanley	Lower Target	Equal Weight	$69.00 ➝ $63.00	Low
4/12/2022	Royal Bank of Canada	Boost Target	Outperform	$76.00 ➝ $77.00	Low
4/12/2022	Piper Sandler	Boost Target		$71.00 ➝ $72.00	Low
4/4/2022	Piper Sandler	Lower Target	Neutral	$77.00 ➝ $71.00	Medium
3/22/2022	Wells Fargo & Company	Lower Target	Equal Weight	$70.00 ➝ $63.00	Low
3/10/2022	Barclays	Lower Target	Underweight	$63.00 ➝ $56.00	High
3/8/2022	BMO Capital Markets	Initiated Coverage	Hold	$65.00	Medium
3/7/2022	Royal Bank of Canada	Lower Target	Outperform	$85.00 ➝ $77.00	High
2/28/2022	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$75.00 ➝ $65.00	Low
2/8/2022	Mizuho	Lower Target	Buy	$81.00 ➝ $75.00	Low
2/3/2022	Maxim Group	Lower Target		$88.00 ➝ $84.00	High
2/3/2022	Oppenheimer	Lower Target		$100.00 ➝ $90.00	High
2/2/2022	Morgan Stanley	Lower Target	Equal Weight	$72.00 ➝ $69.00	High
2/2/2022	Truist Financial	Lower Target	Hold	$77.00 ➝ $75.00	High
2/2/2022	Bank of America	Lower Target	Neutral	$73.00 ➝ $71.00	Medium
2/2/2022	BMO Capital Markets	Lower Target	Outperform	$85.00 ➝ $75.00	Medium
2/2/2022	Royal Bank of Canada	Lower Target	Outperform	$87.00 ➝ $85.00	Medium
2/2/2022	Wells Fargo & Company	Lower Target	Equal Weight	$72.00 ➝ $70.00	Medium
1/28/2022	Argus	Upgrade	Hold ➝ Buy	$75.00	High
1/18/2022	Morgan Stanley	Lower Target	Equal Weight	$74.00 ➝ $72.00	Low
1/14/2022	BMO Capital Markets	Initiated Coverage	Buy	$85.00	Low
1/6/2022	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$84.00 ➝ $74.00	Low
12/15/2021	BMO Capital Markets	Reiterated Rating	Buy		Medium
12/14/2021	SVB Leerink	Reiterated Rating	Buy		Medium
12/8/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$72.00	Medium
12/6/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$80.00	Low
11/19/2021	Piper Sandler	Initiated Coverage	Neutral	$77.00	Medium
11/18/2021	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$72.00 ➝ $85.00	Medium
10/31/2021	Evercore ISI	Reiterated Rating	Buy		Medium
10/29/2021	SVB Leerink	Lower Target	Outperform	$77.00 ➝ $75.00	High
10/12/2021	Morgan Stanley	Boost Target	Overweight	$83.00 ➝ $84.00	Medium
8/27/2021	Morgan Stanley	Reiterated Rating	Buy	$83.00	Low
8/23/2021	Royal Bank of Canada	Reiterated Rating	Buy	C$84.00	Low
7/30/2021	SVB Leerink	Boost Target	Outperform	$74.00 ➝ $77.00	Low
7/30/2021	BMO Capital Markets	Boost Target	Market Perform	$67.00 ➝ $72.00	Low
7/30/2021	Royal Bank of Canada	Boost Target	Outperform	$81.00 ➝ $84.00	Medium
6/28/2021	Oppenheimer	Initiated Coverage	Buy	$100.00	Low
5/7/2021	Jefferies Financial Group	Reiterated Rating	Buy	$80.00	Low
5/3/2021	Morgan Stanley	Boost Target	Overweight	$81.00 ➝ $83.00	High
4/30/2021	SVB Leerink	Boost Target	Outperform	$72.00 ➝ $74.00	Medium
4/30/2021	Needham & Company LLC	Reiterated Rating	Hold		High
4/19/2021	Morgan Stanley	Lower Target	Overweight	$87.00 ➝ $81.00	Low
4/1/2021	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$80.00	Medium
3/30/2021	Redburn Partners	Upgrade	Neutral ➝ Buy		Low
2/11/2021	SVB Leerink	Lower Target	Outperform	$73.00 ➝ $72.00	Low
2/5/2021	SVB Leerink	Lower Target	Outperform	$74.00 ➝ $73.00	High
2/5/2021	Credit Suisse Group	Boost Target	Neutral	$65.00 ➝ $66.00	High
2/5/2021	Morgan Stanley	Boost Target	Overweight	$83.00 ➝ $87.00	High
1/19/2021	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$83.00	High
1/4/2021	Guggenheim	Upgrade	Neutral ➝ Buy		N/A
12/22/2020	Smith Barney Citigroup	Lower Target		$75.00 ➝ $72.00	Low
12/18/2020	Truist Financial	Lower Target		$67.00 ➝ $625.00	High
12/17/2020	Oppenheimer	Lower Target	Outperform	$105.00 ➝ $100.00	Low
12/16/2020	BMO Capital Markets	Lower Target	Market Perform	$64.00 ➝ $62.00	Low
12/16/2020	Credit Suisse Group	Lower Target	Neutral	$70.00 ➝ $65.00	Low
12/16/2020	Robert W. Baird	Boost Target	Neutral	$63.00 ➝ $67.00	Low
12/15/2020	Piper Sandler	Lower Target	Overweight	$84.00 ➝ $80.00	Low
12/14/2020	Redburn Partners	Initiated Coverage	Neutral		Low
12/8/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
11/3/2020	Morgan Stanley	Reiterated Rating	Equal Weight	$67.00	Low
10/29/2020	Cantor Fitzgerald	Reiterated Rating	Overweight	$84.00 ➝ $86.00	Medium
10/29/2020	BMO Capital Markets	Lower Target	Market Perform	$74.00 ➝ $64.00	Medium
10/29/2020	Barclays	Lower Target		$67.00 ➝ $62.00	Medium
10/29/2020	Wells Fargo & Company	Lower Target	Equal Weight	$69.00 ➝ $63.00	Low
10/29/2020	Piper Sandler	Lower Target	Overweight	$95.00 ➝ $84.00	Medium
10/29/2020	SVB Leerink	Lower Target	Outperform	$88.00 ➝ $79.00	Low
10/28/2020	UBS Group	Initiated Coverage	Neutral	$61.00	Medium
9/30/2020	Jefferies Financial Group	Initiated Coverage	Buy	$78.00	Low
9/18/2020	Royal Bank of Canada	Boost Target		$82.00 ➝ $86.00	Low
9/15/2020	Royal Bank of Canada	Lower Target	Outperform	$84.00 ➝ $82.00	Low
9/15/2020	Maxim Group	Upgrade	Hold ➝ Buy	$88.00	Low
9/14/2020	SVB Leerink	Lower Target	Outperform	$94.00 ➝ $88.00	High
9/14/2020	Raymond James	Reiterated Rating	Hold		High
9/10/2020	Oppenheimer	Boost Target	Outperform	$90.00 ➝ $105.00	Medium
8/20/2020	Truist Financial	Lower Target		$74.00 ➝ $67.00	Low
8/19/2020	Piper Sandler	Lower Target	Overweight	$85.00 ➝ $83.00	Medium
8/19/2020	Jefferies Financial Group	Lower Target		$97.00 ➝ $78.00	Medium
8/19/2020	Wells Fargo & Company	Boost Target	Equal Weight	$69.00 ➝ $76.00	High
8/19/2020	BMO Capital Markets	Boost Target	Market Perform	$74.00 ➝ $79.00	Medium
8/19/2020	Cantor Fitzgerald	Lower Target	Overweight	$86.00 ➝ $84.00	Medium
8/7/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
8/3/2020	Citigroup	Boost Target		$78.00 ➝ $80.00	Low
7/31/2020	SVB Leerink	Reiterated Rating	Buy	$95.00	High
7/31/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$86.00	High
7/31/2020	Piper Sandler	Lower Target	Overweight	$90.00 ➝ $85.00	Medium
7/31/2020	Credit Suisse Group	Lower Target	Neutral	$75.00 ➝ $73.00	Medium
7/31/2020	SunTrust Banks	Boost Target	Hold	$73.00 ➝ $74.00	Medium
7/31/2020	Royal Bank of Canada	Lower Target	Outperform	$89.00 ➝ $87.00	Medium
7/31/2020	Morgan Stanley	Lower Target	Equal Weight	$80.00 ➝ $79.00	Medium
7/31/2020	Wells Fargo & Company	Lower Target	Equal Weight	$87.00 ➝ $76.00	Medium
7/28/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold	$85.00	Low
7/21/2020	Jefferies Financial Group	Reiterated Rating	Buy	$97.00	Low
7/20/2020	Credit Suisse Group	Upgrade	Underperform ➝ Neutral	$64.00 ➝ $75.00	Low
7/15/2020	Morgan Stanley	Boost Target	Equal Weight	$77.00 ➝ $80.00	Low
7/6/2020	Royal Bank of Canada	Reiterated Rating	Buy		Low
6/30/2020	Needham & Company LLC	Reiterated Rating	Hold		High
6/29/2020	Robert W. Baird	Reiterated Rating	Hold	$76.00	High
6/22/2020	Jefferies Financial Group	Reiterated Rating	Buy	$97.00	Low
6/15/2020	DZ Bank	Reiterated Rating	Buy		Medium
6/8/2020	Piper Sandler	Reiterated Rating	Buy	$90.00	Low
6/3/2020	Royal Bank of Canada	Reiterated Rating	Buy	$88.00	High
6/3/2020	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$85.00 ➝ $94.00	Low
6/2/2020	Maxim Group	Reiterated Rating	Hold		High
6/1/2020	Needham & Company LLC	Reiterated Rating	Hold		High
5/26/2020	SunTrust Banks	Upgrade	Sell ➝ Hold	$70.00 ➝ $73.00	Medium
5/21/2020	Piper Sandler	Reiterated Rating	Buy	$90.00	Low
5/21/2020	Robert W. Baird	Reiterated Rating	Hold	$75.00	Low
5/18/2020	Oppenheimer	Reiterated Rating	Buy		High
5/13/2020	Mizuho	Reiterated Rating	Buy	$81.00	Low
5/13/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold	$85.00	High
5/5/2020	Royal Bank of Canada	Reiterated Rating	Buy	$88.00	Low
5/1/2020	Wells Fargo & Company	Reiterated Rating	Hold	$84.00	Low
5/1/2020	SVB Leerink	Boost Target	Market Perform	$68.00 ➝ $85.00	Low
5/1/2020	Oppenheimer	Boost Target	Outperform	$80.00 ➝ $90.00	Low
5/1/2020	Morgan Stanley	Boost Target	Equal Weight	$75.00 ➝ $77.00	Low
5/1/2020	Raymond James	Downgrade	Outperform ➝ Market Perform		Low
5/1/2020	SunTrust Banks	Downgrade	Hold ➝ Sell	$70.00	Low
5/1/2020	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral		Low
4/30/2020	Maxim Group	Reiterated Rating	Hold		High
4/29/2020	Oppenheimer	Initiated Coverage	Buy	$80.00	Medium
4/29/2020	Robert W. Baird	Reiterated Rating	Hold	$76.00	Medium
4/29/2020	Cfra	Boost Target	Sell	$71.00 ➝ $74.00	Medium
4/29/2020	Mizuho	Reiterated Rating	Buy	$81.00	Low
4/27/2020	UBS Group	Downgrade	Buy ➝ Neutral	$77.00 ➝ $80.00	Low
4/23/2020	Royal Bank of Canada	Reiterated Rating	Buy	$85.00	Low
4/23/2020	Mizuho	Initiated Coverage	Buy	$81.00	Low
4/23/2020	Raymond James	Reiterated Rating	Buy	$80.00	Low
4/20/2020	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$79.00	Medium
4/20/2020	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$87.00	Medium
4/19/2020	Needham & Company LLC	Reiterated Rating	Hold		High
4/18/2020	Maxim Group	Initiated Coverage	Hold		High
4/17/2020	Credit Suisse Group	Reiterated Rating	Sell	$60.00	High
4/17/2020	Royal Bank of Canada	Reiterated Rating	Buy	$85.00	High
4/17/2020	JPMorgan Chase & Co.	Reiterated Rating	Buy		High
4/17/2020	Cfra	Downgrade	Hold ➝ Sell		High
4/16/2020	Piper Sandler	Reiterated Rating	Buy	$90.00	High
4/13/2020	Jefferies Financial Group	Reiterated Rating	Buy	$89.00	High
4/13/2020	Cowen	Reiterated Rating	Buy	$80.00	High
4/13/2020	BMO Capital Markets	Reiterated Rating	Outperform ➝ Buy	$79.00	High
4/13/2020	Needham & Company LLC	Reiterated Rating	Hold		Low
4/7/2020	Cantor Fitzgerald	Boost Target	Overweight	$78.00 ➝ $86.00	High
4/6/2020	Credit Suisse Group	Reiterated Rating	Sell	$60.00	High
3/31/2020	Wolfe Research	Initiated Coverage	Market Perform	$65.00	Low
3/30/2020	SVB Leerink	Reiterated Rating	Hold	$68.00	Low
3/25/2020	Royal Bank of Canada	Reiterated Rating	Buy	$83.00	High
3/25/2020	SunTrust Banks	Reiterated Rating	Hold		High
3/20/2020	Piper Sandler	Upgrade	Neutral ➝ Overweight	$70.00 ➝ $90.00	High
3/18/2020	Royal Bank of Canada	Reiterated Rating	Buy	$83.00	High
3/18/2020	DZ Bank	Upgrade	Hold ➝ Buy	$80.00	High
3/9/2020	Royal Bank of Canada	Downgrade	Top Pick ➝ Outperform	$86.00	High
3/4/2020	Wells Fargo & Company	Boost Target	Overweight	$81.00 ➝ $87.00	Low
3/3/2020	Credit Suisse Group	Reiterated Rating	Underperform		Low
3/2/2020	Mizuho	Initiated Coverage	Buy	$81.00	Low
3/2/2020	HC Wainwright	Downgrade	Buy ➝ Neutral		High
2/28/2020	DZ Bank	Downgrade	Buy ➝ Hold	$80.00	High
2/27/2020	Barclays	Initiated Coverage	Underweight	$62.00	High
2/24/2020	SunTrust Banks	Reiterated Rating	Hold	$70.00	High
2/19/2020	Royal Bank of Canada	Reiterated Rating	Buy	$86.00	Low
2/9/2020	Maxim Group	Reiterated Rating	Hold		Low
2/6/2020	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform	$78.00 ➝ $70.00	High
2/5/2020	Piper Sandler	Lower Target		$75.00 ➝ $70.00	High
2/5/2020	Bank of America	Boost Target	Neutral	$70.00 ➝ $72.00	Low
2/5/2020	Credit Suisse Group	Boost Target	Underperform	$59.00 ➝ $60.00	Low
2/5/2020	JPMorgan Chase & Co.	Reiterated Rating	Buy		Medium
2/5/2020	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$81.00 ➝ $80.00	Medium
1/21/2020	Guggenheim	Downgrade	Buy ➝ Neutral		Low
1/3/2020	Oppenheimer	Upgrade	Market Perform ➝ Outperform		Low
1/2/2020	Cowen	Reiterated Rating	Buy	$85.00	Low
12/13/2019	Credit Suisse Group	Downgrade	Neutral ➝ Underperform	$67.00 ➝ $63.00	High
11/12/2019	SunTrust Banks	Initiated Coverage	Hold	$70.00	Low
10/25/2019	Guggenheim	Set Target	Buy	$86.00	High
10/25/2019	Wells Fargo & Company	Set Target	Buy	$81.00	N/A
10/25/2019	Robert W. Baird	Set Target	Hold	$76.00	N/A
10/25/2019	Morgan Stanley	Set Target	Hold	$75.00	N/A
10/25/2019	Oppenheimer	Lower Target	Outperform	$85.00 ➝ $80.00	Low
10/25/2019	Maxim Group	Downgrade	Buy ➝ Hold		High
10/25/2019	Cantor Fitzgerald	Lower Target	Overweight	$88.00 ➝ $85.00	High
10/16/2019	Bank of America	Initiated Coverage	Neutral	$70.00	Low
10/15/2019	Mizuho	Set Target	Buy	$81.00	Low
8/23/2019	Raymond James	Set Target	Buy	$85.00	Low
7/31/2019	BMO Capital Markets	Set Target	Buy	$82.00	Low
7/31/2019	Citigroup	Set Target	Buy	$78.00	Low
7/31/2019	Maxim Group	Set Target	Buy	$84.00	N/A
7/31/2019	Credit Suisse Group	Lower Target	Neutral	$70.00 ➝ $67.00	Medium
7/31/2019	JPMorgan Chase & Co.	Reiterated Rating	Buy	$85.00	High
7/31/2019	Raymond James	Boost Target	Strong-Buy	$83.00 ➝ $86.00	High
7/29/2019	Royal Bank of Canada	Upgrade	Outperform ➝ Top Pick	$91.00	Low
7/15/2019	Needham & Company LLC	Reiterated Rating	Hold		Low
7/15/2019	Jefferies Financial Group	Set Target	Buy	$95.00	Low
7/15/2019	Mizuho	Set Target	Buy	$88.00	Low
7/15/2019	Morgan Stanley	Set Target	Hold	$82.00	Low
7/15/2019	Cantor Fitzgerald	Set Target	Buy	$88.00	Low
7/15/2019	BMO Capital Markets	Set Target	Buy	$76.00	Low
7/15/2019	Maxim Group	Set Target	Buy	$84.00	Low
7/15/2019	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$68.00 ➝ $88.00	High
7/12/2019	Oppenheimer	Set Target	Buy	$85.00	High
7/2/2019	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low
6/19/2019	Mizuho	Reiterated Rating	Buy	$88.00	Low
5/28/2019	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$70.00 ➝ $60.00	High
5/22/2019	Citigroup	Upgrade	Neutral ➝ Buy	$66.80	Low
5/20/2019	Credit Suisse Group	Initiated Coverage	Neutral	$70.00	Low
5/17/2019	Mizuho	Set Target	Buy	$88.00	Low
5/17/2019	Evercore ISI	Reiterated Rating	Buy		Low
5/10/2019	Mizuho	Set Target	Buy	$88.00	High
5/7/2019	JPMorgan Chase & Co.	Reiterated Rating	Buy	$87.00	Low
5/6/2019	Needham & Company LLC	Reiterated Rating	Hold		High
5/3/2019	Raymond James	Set Target	Buy	$83.00	Low
5/3/2019	Cowen	Reiterated Rating	Buy		High
4/28/2019	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low
4/26/2019	Sanford C. Bernstein	Initiated Coverage	Outperform ➝ Outperform	$82.00	Medium

(Data available from 4/26/2019 forward)

News Sentiment Rating

0.70 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

25 very positive mentions
17 positive mentions
5 negative mentions
3 very negative mentions

Mentions as of

9/29/2023

26 very positive mentions
23 positive mentions
3 negative mentions
3 very negative mentions

Mentions as of

10/29/2023

19 very positive mentions
25 positive mentions
5 negative mentions
1 very negative mentions

Mentions as of

11/28/2023

33 very positive mentions
26 positive mentions
5 negative mentions
7 very negative mentions

Mentions as of

12/28/2023

32 very positive mentions
45 positive mentions
4 negative mentions
15 very negative mentions

Mentions as of

1/27/2024

46 very positive mentions
47 positive mentions
11 negative mentions
7 very negative mentions

Mentions as of

2/26/2024

26 very positive mentions
47 positive mentions
5 negative mentions
0 very negative mentions

Mentions as of

3/27/2024

46 very positive mentions
27 positive mentions
13 negative mentions
2 very negative mentions

Mentions as of

4/26/2024

Current Sentiment

Recent Stories by Sentiment

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Today's Range

Now: $65.42

$64.63

$66.35

50 Day Range

MA: $71.28

$65.27

$75.94

52 Week Range

Now: $65.42

$64.63

$87.86

Volume

12,349,126 shs

Average Volume

7,477,028 shs

Market Capitalization

$81.45 billion

P/E Ratio

14.54

Dividend Yield

4.59%

Beta

0.19

Frequently Asked Questions

What sell-side analysts currently cover shares of Gilead Sciences?: The following equities research analysts have issued stock ratings on Gilead Sciences in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Leerink Partnrs, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Royal Bank of Canada, StockNews.com, TD Cowen, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for GILD.
What is the current price target for Gilead Sciences?: 15 Wall Street analysts have set twelve-month price targets for Gilead Sciences in the last year. Their average twelve-month price target is $83.87, suggesting a possible upside of 28.2%. Oppenheimer Holdings Inc. has the highest price target set, predicting GILD will reach $105.00 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of $69.00 for Gilead Sciences in the next year.
View the latest price targets for GILD.
What is the current consensus analyst rating for Gilead Sciences?: Gilead Sciences currently has 11 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GILD, but not buy more shares or sell existing shares.
View the latest ratings for GILD.
What other companies compete with Gilead Sciences?: Other companies that are similar to Gilead Sciences include Seagen, Biogen, Amgen, Moderna and argenx. Learn More about companies similar to Gilead Sciences.
How do I contact Gilead Sciences' investor relations team?: Gilead Sciences' physical mailing address is 333 LAKESIDE DRIVE, FOSTER CITY CA, 94404. The biopharmaceutical company's listed phone number is (650) 574-3000 and its investor relations email address is [email protected]. The official website for Gilead Sciences is www.gilead.com. Learn More about contacing Gilead Sciences investor relations.

Gilead Sciences - GILD Stock Price Target and Predictions

Analyst Price Target for GILD

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.70 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Gilead Sciences?

What is the current price target for Gilead Sciences?

What is the current consensus analyst rating for Gilead Sciences?

What other companies compete with Gilead Sciences?

How do I contact Gilead Sciences' investor relations team?